Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Pediatric Neurology · Genetic Epilepsy with Febrile Seizures Plus

Treating GEFS+: Daily Care and Emergency Response

At a Glance

GEFS+ treatment depends on seizure type, frequency, and duration. Brief fever-related seizures may not need daily medicine, but seizures without fever or frequent or prolonged events may. A written plan should explain rescue medicine use and when a 5-minute convulsive seizure needs emergency help.

Managing Genetic Epilepsy with Febrile Seizures Plus (GEFS+) is a balancing act. Because the condition is a spectrum, there is no “one-size-fits-all” treatment. Your care team will tailor a plan based on your child’s specific seizure types, how often they happen, and their genetic results [1][2].

Daily Management: To Treat or Not to Treat?

The decision to start a daily anti-seizure medication (also called a maintenance or prophylactic medication) depends on the “burden” of the seizures.

  • Observation and Reassurance: If your child only has isolated febrile seizures that are brief and infrequent, daily medication is usually not recommended [3]. In these cases, the risks and side effects of daily drugs often outweigh the benefits, as these seizures are usually self-limited and outgrown [3][4]. (Note that while fever-reducing medicines may improve comfort, they do not reliably prevent febrile seizures.)
  • When Medication is Considered: Your doctor may recommend daily treatment if your child develops afebrile seizures (seizures without fever), experiences multiple different seizure types, or has very frequent or prolonged events [1][2]. The goal of daily medication is not necessarily to “cure” the epilepsy, but to reduce the number of seizures and improve your child’s quality of life [5].

The Sodium-Channel Blocker Nuance

A unique challenge in GEFS+ (especially when SCN1A is involved) is the use of a class of drugs called sodium-channel blockers (such as carbamazepine, oxcarbazepine, or lamotrigine).

  • The Risk of Aggravation: In many SCN1A mutations—particularly those seen in Dravet syndrome—these drugs can aggravate seizures [6][7].
  • The Exception: In some milder forms of GEFS+, these same medications might actually be helpful [8][9]. The functional effect of a variant is often unknown on standard lab reports.

Because of this, it is vital that a specialist reviews your child’s phenotype before starting or avoiding these specific medications [10]. Never start, stop, or avoid an antiseizure medication based on this guide; always consult your doctor.

Managing Seizure Emergencies

While most seizures end on their own within a minute or two, any convulsive seizure lasting 5 minutes or more is considered a medical emergency called status epilepticus [11][12].

Seizure First Aid Protocol:

  1. Start timing the seizure immediately.
  2. Protect the child from injury (move hard objects away, place something soft under the head).
  3. Turn them on their side if possible to keep the airway clear.
  4. Do NOT restrain their movements.
  5. Do NOT put anything in their mouth.

Rescue Medications

Your doctor will likely provide a Seizure Action Plan that includes a “rescue medication.” These are fast-acting drugs designed to stop a seizure in progress. Common options include:

  • Buccal Midazolam: A liquid placed between the cheek and the gum [13].
  • Intranasal Midazolam: A spray into the nose [14].
  • Rectal Diazepam: A gel administered rectally [13].

These are typically given if a convulsive seizure reaches the 5-minute mark, though your doctor may set a specific threshold for your child [12][13]. Call your local emergency number if the seizure continues, if the child has trouble breathing, or if they suffer repeated seizures without recovering.

After the Seizure: What to Watch For

Most children are sleepy or confused after a seizure (the post-ictal state). However, if your child remains unresponsive for a prolonged time, fails to return toward baseline, or shows difficulty breathing, they require urgent evaluation. Prolonged confusion with subtle signs might occasionally indicate non-convulsive status epilepticus, a condition that requires formal clinical assessment and an EEG to diagnose—it is not something a parent can diagnose at home [15][16][17].

Safety and Support

The most effective tool you have is a written Seizure Action Plan [13]. This document should clearly state your child’s weight-based rescue dose, when to give it, and exactly when to call emergency services [12]. Sharing this with teachers, family members, and caregivers ensures your child is safe no matter where they are.

Common questions in this guide

Does every child with GEFS+ need a daily seizure medicine?
No. Children with only brief, infrequent febrile seizures often do not need daily medicine, while treatment may be considered for seizures without fever, several seizure types, or frequent or prolonged events. The child's clinician weighs seizure burden, quality of life, and medication side effects.
Can some seizure medicines make GEFS+ seizures worse?
Yes. Sodium-channel blockers such as carbamazepine, oxcarbazepine, and lamotrigine can worsen seizures in some children with SCN1A variants, especially when the pattern resembles Dravet syndrome, although they may help some milder GEFS+ cases. Do not start, stop, or avoid a medicine without guidance from the child's epilepsy specialist.
What should I do first when my child's seizure begins?
Start a timer, move hard objects away, and place something soft under the child's head. Turn the child on their side if possible, but do not restrain them or put anything in their mouth. Follow the child's written emergency plan and seek emergency help if the seizure reaches the plan's time limit, lasts 5 minutes, affects breathing, or repeats without recovery.
When should I give my child's rescue medicine?
Rescue medicines such as buccal or intranasal midazolam and rectal diazepam are commonly given when a convulsive seizure reaches 5 minutes, but the child's doctor may set a different threshold. Use the dose and timing written in the Seizure Action Plan, and call the local emergency number if the seizure continues, breathing is difficult, or seizures repeat without recovery.
How can I tell if my child needs urgent care after a seizure?
Sleepiness and confusion can be normal after a seizure, but prolonged unresponsiveness, failure to move back toward normal, or trouble breathing needs urgent medical evaluation. Ongoing confusion with subtle seizure signs can sometimes be non-convulsive status epilepticus, which requires clinical assessment and an EEG, a test that records brain activity; caregivers should not try to diagnose it at home.
What should a GEFS+ Seizure Action Plan include?
It should state the child's weight-based rescue dose, exactly when to give it, when to call emergency services, and what recovery signs require help. Share the plan with school staff, family members, and other caregivers, and practice using the rescue medicine before an emergency.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Genetic epilepsy with febrile seizure plus.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does my child's genetic variant have a known functional effect, and how does that specific information guide our choice of medication?
  2. 2.Given my child's current seizure frequency, are we at the point where the benefits of daily medication outweigh the potential side effects?
  3. 3.If we use a rescue medication like midazolam, at exactly how many minutes should I administer it, and when should I call emergency services?
  4. 4.Can you help me create a written Seizure Action Plan that I can share with my child's school or daycare?
  5. 5.How will we know if my child is experiencing 'non-convulsive' status epilepticus, and what should I look for after a seizure ends?
  6. 6.Are there specific 'red flag' medications that we should absolutely avoid at the pharmacy or if we end up in an emergency room?

References

References (17)
  1. 1

    Genetic literacy series: genetic epilepsy with febrile seizures plus.

    Myers KA, Scheffer IE, Berkovic SF,

    Epileptic disorders : international epilepsy journal with videotape 2018; (20(4)):232-238 doi:10.1684/epd.2018.0985.

    PMID: 30078767
  2. 2

    Genetic epilepsy with febrile seizures plus: Refining the spectrum.

    Zhang YH, Burgess R, Malone JP, et al.

    Neurology 2017; (89(12)):1210-1219 doi:10.1212/WNL.0000000000004384.

    PMID: 28842445
  3. 3

    Febrile seizures and genetic epilepsy with febrile seizures plus (GEFS+).

    Camfield P, Camfield C

    Epileptic disorders : international epilepsy journal with videotape 2015; (17(2)):124-33 doi:10.1684/epd.2015.0737.

    PMID: 25917466
  4. 4

    Outcomes and comorbidities of SCN1A-related seizure disorders.

    de Lange IM, Gunning B, Sonsma ACM, et al.

    Epilepsy & behavior : E&B 2019; (90()):252-259 doi:10.1016/j.yebeh.2018.09.041.

    PMID: 30527252
  5. 5

    Clinical and genetics spectrum of 392 Chinese patients with genetic epilepsy with febrile seizures plus.

    Chen S, Quan Y, Yin F, Peng J

    Journal of neurology 2025; (273(1)):18.

    PMID: 41366559
  6. 6

    From Symptomatic Therapies to Disease-Modifying Approaches for Neuronal Sodium Channel Disorders.

    Dinoi G, Canfora I, D'Agnano D, et al.

    International journal of molecular sciences 2025; (27(1)) doi:10.3390/ijms27010032.

    PMID: 41515912
  7. 7

    Acute effect of antiseizure drugs on background oscillations in Scn1a A1783V Dravet syndrome mouse model.

    Quinn S, Brusel M, Ovadia M, Rubinstein M

    Frontiers in pharmacology 2023; (14()):1118216 doi:10.3389/fphar.2023.1118216.

    PMID: 37021051
  8. 8

    The gain of function SCN1A disorder spectrum: novel epilepsy phenotypes and therapeutic implications.

    Brunklaus A, Brünger T, Feng T, et al.

    Brain : a journal of neurology 2022; (145(11)):3816-3831 doi:10.1093/brain/awac210.

    PMID: 35696452
  9. 9

    Gain of function SCN1A disease-causing variants: Expanding the phenotypic spectrum and functional studies guiding the choice of effective antiseizure medication.

    Matricardi S, Cestèle S, Trivisano M, et al.

    Epilepsia 2023; (64(5)):1331-1347 doi:10.1111/epi.17509.

    PMID: 36636894
  10. 10

    Epilepsy-associated Variants of a Single SCN1A Codon exhibit Divergent Functional Properties.

    Liebovitz LN, Thompson CH, Laux LL, George AL

    bioRxiv : the preprint server for biology 2025; doi:10.1101/2025.10.16.682932.

    PMID: 41279753
  11. 11

    Optimal Management of Status Epilepticus in Children in the Emergency Setting: A Review of Recent Advances.

    Messahel S, Bracken L, Appleton R

    Open access emergency medicine : OAEM 2022; (14()):491-506 doi:10.2147/OAEM.S293258.

    PMID: 36158897
  12. 12

    Pre-hospital and emergency department treatment of convulsive status epilepticus in adults: an evidence synthesis.

    Cruickshank M, Imamura M, Booth C, et al.

    Health technology assessment (Winchester, England) 2022; (26(20)):1-76 doi:10.3310/RSVK2062.

    PMID: 35333156
  13. 13

    Recommendations for the community-based management of prolonged convulsive seizures in children in Europe.

    Vigevano F, Arzimanoglou A, Auvin S, et al.

    BMC pediatrics 2026; (26(1)):135.

    PMID: 41593567
  14. 14

    Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society.

    Glauser T, Shinnar S, Gloss D, et al.

    Epilepsy currents 2016; (16(1)):48-61 doi:10.5698/1535-7597-16.1.48.

    PMID: 26900382
  15. 15

    Nonconvulsive status epilepticus after cessation of convulsive status epilepticus in pediatric intensive care unit patients.

    Chen J, Xie L, Hu Y, et al.

    Epilepsy & behavior : E&B 2018; (82()):68-73 doi:10.1016/j.yebeh.2018.02.008.

    PMID: 29587188
  16. 16

    Clinical Features and Management of Status Epilepticus in the Pediatric Intensive Care Unit.

    Soydan E, Guzin Y, Topal S, et al.

    Pediatric emergency care 2023; (39(3)):142-147 doi:10.1097/PEC.0000000000002915.

    PMID: 36790917
  17. 17

    EEG Monitoring After Convulsive Status Epilepticus.

    Fung FW, Abend NS

    Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society 2020; (37(5)):406-410 doi:10.1097/WNP.0000000000000664.

    PMID: 32890062

This page is for informational purposes only and does not constitute medical advice. A child's neurologist or other clinician should individualize GEFS+ medicines, rescue-medication timing, and emergency instructions for your child.